CTS Corp (CTS) Stock Up 4.0% but GF Value Says Overvalued -- GF Score: 73/100
On May 22, 2026, CTS Corp (CTS) shares rose 4.0% today, closing at $62.32. The stock has performed well recently, reflecting a 52-week range of $36.03 to $62.45
CTS - CTS Corporation
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
Stock News
Recent Price Trend in CTS (CTS) is Your Friend, Here's Why
CTS (CTS) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
CTS (CTS) Is Up 8.33% in One Week: What You Should Know
Does CTS (CTS) have what it takes to be a top stock pick for momentum investors? Let's find out.
CTS Corporation Declares a Dividend
LISLE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of CTS Corporation (NYSE: CTS) has declared a cash dividend of $0.04 per share on outstanding shares of common stock, without par value, to be paid on July 24, 2026, to shareholders of record at the close of business on June 26, 2026.
CTS Corporation (CTS) Q1 2026 Earnings Call Transcript
CTS Corporation (CTS) Q1 2026 Earnings Call Transcript
CTS (CTS) Q1 Earnings and Revenues Surpass Estimates
CTS (CTS) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.44 per share a year ago.
CTS Announces First Quarter 2026 Results
LISLE, Ill., April 29, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly engineered solutions that “Sense, Connect and Move,” today announced results for the first quarter of 2026.
CTS Corp (CTS) Stock Down 3.0% but Still Overvalued -- GF Score: 76/100
On April 28, 2026, CTS Corp (CTS) shares fell 3.0% to a current price of $54.27. This drop comes amid a 52-week range of $36.03 to $59.66, reflecting a consider
CTS (NYSE:CTS) Stock Crosses Above 200 Day Moving Average – Here’s What Happened
CTS Corporation (NYSE: CTS - Get Free Report) shares crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $46.72 and traded as high as $55.87. CTS shares last traded at $54.8730, with a volume of 168,498 shares traded. Analyst Upgrades and Downgrades Several research analysts have
CTS Corporation Announces Date for First Quarter 2026 Earnings Release and Conference Call
LISLE, Ill., April 14, 2026 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS) will release its earnings for the first quarter 2026 at approximately 8:00 a.m.
CTS or OSIS: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Electronics - Miscellaneous Components sector might want to consider either CTS (CTS) or OSI Systems (OSIS). But which of these two companies is the best option for those looking for undervalued stocks?
CTS Eventim: Lack Of Visibility Keeps Me On Hold
CTS Eventim AG & Co. KGaA is rated Hold due to limited near-term earnings visibility despite strong core ticketing and promising venue operations. Ticketing remains robust, with 177 million tickets sold in 2025 and two-thirds of retail volume now international, reducing reliance on Germany. CEVMF's venue operations are emerging as a high-margin growth driver, exemplified by the Unipol Dome outperforming initial ticket price expectations.
CTS (NYSE:CTS) Stock Price Crosses Above Two Hundred Day Moving Average – Here’s What Happened
CTS Corporation (NYSE: CTS - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $45.76 and traded as high as $48.93. CTS shares last traded at $48.4710, with a volume of 91,772 shares trading hands. Wall Street Analysts Forecast Growth Several analysts have
Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the global launch of the Gibco™ CTS™ Compleo™ Fill and Finish System, an automated, functionally closed solution designed to streamline formulation and filling in cell therapy manufacturing. Because cell therapies often begin with patient-derived cells, manufacturing workflows must accommodate variability in cell count, concentration and viability. As more therapies move toward c.
CTS Eventim AG & Co. KGaA (CEVMY) Q4 2025 Earnings Call Transcript
CTS Eventim AG & Co. KGaA (CEVMY) Q4 2025 Earnings Call Transcript
CTS vs. OSIS: Which Stock Is the Better Value Option?
Investors interested in stocks from the Electronics - Miscellaneous Components sector have probably already heard of CTS (CTS) and OSI Systems (OSIS). But which of these two companies is the best option for those looking for undervalued stocks?
CTS or OSIS: Which Is the Better Value Stock Right Now?
Investors interested in Electronics - Miscellaneous Components stocks are likely familiar with CTS (CTS) and OSI Systems (OSIS). But which of these two stocks presents investors with the better value opportunity right now?
CTS Corporation: Revisiting Our Investment Theses, Maintain Overweight
CTS Corporation (CTS) remains rated Overweight with a Buy recommendation. Accretive acquisitions and visible pipeline of orders drive compelling growth and provide multi-year revenue visibility. Design-in stickiness and lifecycle qualification create durable, predictable revenues despite competitive pricing pressures.
CTS vs. OSIS: Which Stock Is the Better Value Option?
Investors looking for stocks in the Electronics - Miscellaneous Components sector might want to consider either CTS (CTS) or OSI Systems (OSIS). But which of these two companies is the best option for those looking for undervalued stocks?
What Makes CTS (CTS) a New Buy Stock
CTS (CTS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).